Biomedical Engineering Reference
In-Depth Information
251. Yu J, Du KT, Fang Q, Gu Y, Mihardja SS, Sievers RE, Wu JC, Lee RJ (2010) The use of
human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the
repair of myocardial infarction in the rat. Biomaterials 31(27):7012-7020
252. Lim GJ, Zare S, Van Dyke M, Atala A (2010) Cell microencapsulation. Adv Exp Med Biol
670:126-136
253. Liu ZC, Chang TM (2010) Artificial cell microencapsulated stem cells in regenerative
medicine, tissue engineering and cell therapy. Adv Exp Med Biol 670:68-79
254. Murua A, Portero A, Orive G, Hernandez RM, de Castro M, Pedraz JL (2008) Cell
microencapsulation
technology:
towards
clinical
application.
J
Control
Release
132(2):76-83
255. Santos E, Zarate J, Orive G, Hernandez RM, Pedraz JL (2010) Biomaterials in cell
microencapsulation. Adv Exp Med Biol 670:5-21
256. Christman KL, Lee RJ (2006) Biomaterials for the treatment of myocardial infarction. J Am
Coll Cardiol 48(5):907-913
257. Leoni L, Desai TA (2004) Micromachined biocapsules for cell-based sensing and delivery.
Adv Drug Deliv Rev 56(2):211-229
258. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, Granot Y, Cohen S
(2000) Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?
Circulation 102(19(Suppl 3)):III56-III61
259. Piao H, Kwon JS, Piao S, Sohn JH, Lee YS, Bae JW, Hwang KK, Kim DW, Jeon O, Kim BS,
Park YB, Cho MC (2007) Effects of cardiac patches engineered with bone marrow-derived
mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials
28(4):641-649
260. Jin J, Jeong SI, Shin YM, Lim KS, Shin H, Lee YM, Koh HC, Kim KS (2009)
Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone)
scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail
11(2):147-153
261. Fitzpatrick JR, Frederick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR,
Gambogi AJ, Liu JP, Paulson EC, Woo YJ (2010) Tissue-engineered pro-angiogenic
fibroblast scaffold improves myocardial perfusion and function and limits ventricular
remodeling after infarction. J Thorac Cardiovasc Surg 140(3):667-676
262. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib IH, Gepstein L, Levenberg S
(2007) Tissue engineering of vascularized cardiac muscle from human embryonic stem
cells. Circ Res 100(2):263-272
263. Xiang Z, Liao R, Kelly MS, Spector M (2006) Collagen-GAG scaffolds grafted onto
myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. Tissue
Eng 12(9):2467-2478
264. Frederick JR, Fitzpatrick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N,
Smith MJ, Cohen JE, Hiesinger W, Atluri P, Woo YJ (2010) Stromal cell-derived factor-
1alpha
activation
of
tissue-engineered
endothelial
progenitor
cell
matrix
enhances
ventricular
function
after
myocardial
infarction
by
inducing
neovasculogenesis.
Circulation 122(11 Suppl):S107-S117
265. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Three-
dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng
68(1):106-114
266. Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O,
Neuhuber WL, Weyand M, Eschenhagen T (2002) Cardiac grafting of engineered heart
tissue in syngenic rats. Circulation 106(12 Suppl 1):I151-I157
267. Naito
H,
Melnychenko
I,
Didie
M,
Schneiderbanger
K,
Schubert
P,
Rosenkranz
S,
Eschenhagen
T,
Zimmermann
WH
(2006)
Optimizing
engineered
heart
tissue
for
therapeutic applications as surrogate heart muscle. Circulation 114(1 Suppl):I72-I78
268. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, Hess A,
Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T
